Media Summary: Following a discussion on how to monitor patients with Mercy Medical Center's Dr. Anurag Masheshwari explains what to watch for when it comes to Lawrence J. Brandt, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, cite ...
Factors That Impact Clostridium Difficile Infection Recurrence - Detailed Analysis & Overview
Following a discussion on how to monitor patients with Mercy Medical Center's Dr. Anurag Masheshwari explains what to watch for when it comes to Lawrence J. Brandt, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, cite ... Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, explore treatment recommendations for ... After an interim analysis, enrollment in the actoxumab group was stopped owing to higher rates of Richard Haupt, MD, MPH, vice president of Medical Development at Pfrizer Vaccines, explains the risk
Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, review treatment options for multiple- JAMA. 2015;313(17):1719-1727. Read the article at: This video contains a visual explanation of Dale N. Gerding, MD, discusses bezlotoxumab and its use for preventing Sahil Khanna shares strategies for preventing and managing Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, review screening recommendations and ...
Mercy gastroenterologist Dr. Anurag Maheshwari discusses causes and treatment for Dr. Sahil Khanna, a Professor of Medicine in Gastroenterology at Mayo Clinic in Rochester, MN, sharing insights from his article ... ... discusses the management and treatment options for an IBD patient with a Julian Hurdle, PhD, Associate Professor, Center for Dr. Freda Lewis- Hall, Pfizer's Chief Patient Officer discusses
